Massimiliano Salati

30PUBLICATIONS
80CO-AUTHORS
Molecular targetsLiquid biopsiesPredictive and prognostic markersNutritional epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Jun 01, 2026
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase III FIGHT-302 Trial.

|May 22, 2026
Author Correction: CCL3 predicts exceptional response to TGFβ inhibition in basal-like pancreatic cancer enriched in LIF-producing macrophages.

|Oct 31, 2024
CCL3 predicts exceptional response to TGFβ inhibition in basal-like pancreatic cancer enriched in LIF-producing macrophages.

Silvia Pietrobono, Monica Bertolini, Veronica De Vita

|Apr 27, 2024
Nrf2 Plays a Key Role in Erythropoiesis during Aging.

Serge Cedrick Toya Mbiandjeu, Angela Siciliano, Alessandro Mattè

|Apr 08, 2024
Integration of liposomal irinotecan in the first-line treatment of metastatic pancreatic cancer: try to do not think about the white bear.

Davide Melisi, Simona Casalino, Silvia Pietrobono

|Dec 09, 2023
Timing of Initiation of Palliative Chemotherapy in Asymptomatic Patients with Metastatic Pancreatic Cancer: An International Expert Survey and Case-Vignette Study.

Simone Augustinus, Hanneke W M van Laarhoven, Geert A Cirkel

Pageof 5

Frequent Collaborators

11 joint publications

Valeria Merz

5 joint publications

Camilla Zecchetto

4 joint publications

Silvia Pietrobono

4 joint publications

Serena Contarelli